In pancreatic cancer cells’ struggle to survive, the cells choose alternative routes when their main pathways are blocked by drugs. Researchers recently developed a new cocktail of drugs that shrink pancreatic tumors in mice by blocking both the main and alternative pathways that cancer cells use.